Cytokine gene polymorphism in human disease: On-line databases, Supplement 1

Genes and Immunity

Volumn 2, Issue 2, 2001, Pages 61-70

  Bidwell, J ^a   Keen, L ^a   Gallagher, G ^b   Kimberly, R ^c   Huizinga, T ^d   McDermott, M F ^e   Oksenberg, J ^f   McNicholl, J ^g   Pociot, F ^h   Hardt, C ⁱ   D'Alfonso, S ^j  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c University of Alabama at Birmingham   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Immunology Branch   (United States)

^h STENO DIABETES CENTER   (Denmark)

ⁱ UNIVERSITY HOSPITAL ESSEN   (Germany)

^j UNIVERSITY OF EASTERN PIEDMONT   (Italy)

more..

Author keywords

Cytokine gene polymorphism; On line databases

Indexed keywords

CYTOKINE;

GENERAL ASPECTS OF DISEASE; GENETIC DATABASE; GENETIC POLYMORPHISM; GENETICS; HUMAN; INTERNET; MEDLINE; REVIEW;

CYTOKINES; DATABASES, GENETIC; DISEASE; HUMANS; INTERNET; MEDLINE; POLYMORPHISM, GENETIC;

EID: 0035319112     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363733     Document Type: Review

References (131)

1. Bidwell J, Keen L, Gallagher G et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1: 1-17.
2. Bidwell JL, Wood NAP, Morse HR, Olomolaiye OO, Laundy GJ. Human cytokine gene nucleotide sequence alignments, 1998. Eur J Immunogenet 1998; 25: 83-266.
3. Tagiev AF, Surin VL, Lukyanenko AV et al. Polymorphism at codon 117 of the granulocyte/macrophage colony-stimulating factor gene (GM-CSF). Genetika 1995; 31: 1370-1374.
4. Golovleva I, Kandefer-Szerszen M, Beckman L, Lundgren E. Polymorphism in the interferon-alpha gene family. Am J Hum Genet 1996; 59: 570-578.
5. Miterski B, Jaeckel S, Epplen JT, Pohlau D, Hardt C. The interferon gene cluster: a candidate region for MS predisposition? Genes Immun 1999; 1: 37-44.
6. Geidraitis, V, He B, Hillert J. Mutation screening of the interferon-gamma gene as a candidate gene for multiple sclerosis. Eur J Immunogenet 1999; 26: 257-259.
7. Pravica V, Brogan IJ, Hutchinson IV. Rare polymorphisms in the promoter regions of the human interleukin-12 p35 and interleukin-12 p40 subunit genes. Eur J Immunogenet 2000; 27: 35-36.
8. van der Pouw Kraan TCTM, van Veen A, Boeije LCM et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1999; 1: 61-65.
9. Laundy GJ, Spink CF, Keen LJ, Wood NA, Bidwell JL. A novel polymorphism in the human interleukin-13 (IL-13) promoter. Eur J Immunogenet 2000; 27: 53-54.
10. McKenzie ANJ, Culpepper JA, De Waal Malefyt R et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90: 3735-3739.
11. Ahmed S, Ihara K, Sasaki Y, Nakao F, Nishima S, Fujino T, Hara T. Novel polymorphism in the coding region of the IL-13 receptor Alpha' gene: association study with atopic asthma in the Japanese population. [In Process Citation.] Exp Clin Immunogenet 2000; 17: 18-22.
12. Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J Bone Miner Res 2000; 15: 402-414.
13. Denny P, Lord CJ, Hill NJ et al. Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes 1997; 46: 695-700.
14. Suzuki I, Yamaguchi E, Hizawa N, Itoh A, Kawakami Y. A new polymorphism in the 5′ flanking region of the human interleukin (IL)-4 gene. Immunogenetics 1999; 49: 738-739.
15. Takabayashi A, Ihara K, Sasaki Y, Kusuhara K, Nishima S, Hara T. Novel polymorphism in the 5′-untranslated region of the interleukin-4 gene. J Hum Genet 1999; 44: 352-353.
16. Borish L, Mascali JJ, Klinnert M, Leppert M, Rosenwasser LJ. SSC polymorphisms in interleukin genes. Hum Mol Genet 1994; 3: 1710.
17. Marsh DG, Neely JD, Breazeale DR et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994; 264: 1152-1156.
18. Deichmann K, Bardutzky J, Forster J, Heinzmann A, Kuehr J. Common polymorphisms in the coding part of the IL4-receptor gene. Biochem Biophys Res Commun 1997; 231: 696-697.
19. Deichmann K, Kruse S. Personal communication. 1999.
20. Kruse S, Japha T, Tedner M et al. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999; 96: 365-371.
21. Hershey G, Friedrich M, Esswein L, Thomas M, Chatila T. The association of atopy with a gain-of-function mutator in the a subunit of the interleukin 4 receptor. N Engl J Med 1997; 337: 1720-1725.
22. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin-6 (IL6) transcriptional regulation. J Biol Chem 2000; 275: 18138-18144.
23. al Sharif F, Ollier WE, Hajeer AH. A rare polymorphism at position -28 in the human RANTES promoter. Eur J Immunogenet 1999; 26: 373-374.
24. Fryer AA, Spiteri MA, Bianco A et al. The -403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 2000; 1: 509-514.
25. Stewart HS, Ridgway AE, Dixon MJ, Bonshek R, Parveen R, Black G. Heterogeneity in granular corneal dystrophy: identification of three causative mutations in the TGFBI (BIGH3) gene-lessons for corneal amyloidogenesis. Hum Mutat 1999; 14: 126-132.
26. Pantelidis P, Lympany PA, Foley PJ, Fanning GC, Welsh KI, du Bois RM. Polymorphic analysis of the high-affinity tumor necrosis factor receptor 2. Tissue Antigens 1999; 54: 585-591.
27. Komata T, Tsuchiya N, Matsushita M, Hagiwara K, Tokunaga K. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 1999; 53: 527-533.
28. Cartwright N, Demaine A, Jahromi M, Sanders H, Kaminski ER. A study of cytokine protein secretion, frequencies of cytokine expressing cells and IFN-G gene polymorphisms in normal individuals. Transplantation 1999; 68: 1546-1552.
29. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999; 26: 1-3.
30. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101-1108.
31. Maurer M, Kruse N, Giess R, Toyka KV, Rieckmann P. Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis. J Neuroimmunol 2000; 104: 98-100.
32. Tountas NA, Casini-Raggi V, Yang H et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 1999; 117: 806-813.
33. Linker-Israeli M, Wallace DJ, Prehn J et al. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes Immun 1999; 1: 45-52.
34. Obayashi H, Nakamura N, Fukui M et al. Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus. Hum Immunol 1999; 60: 974-978.
35. Huang DR, Pirskanen R, Matell G, Lefvert AK. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis. J Neuroimmunol 1999; 94: 165-171.
36. Kroeger KM, Steer JH, Joyce DA, Abraham LJ. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 2000; 12: 110-119.
37. Maurer M, Kruse N, Giess R, Kyriallis K, Toyka KV, Rieckmann P. Gene polymorphism at position -308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patients. J Neurol 1999; 246: 949-954.
38. Sotgiu S, Pugliatti M, Serra C, Rosati G, Dolei A, Marrosu MG. Tumor necrosis factor 2 allele does not contribute to increased tumor necrosis factor-alpha production in Sardinian multiple sclerosis [letter]. Ann Neurol 1999; 46: 799-800.
39. Skoog T, van't Hooft FM, Kallin B et al. A common functional polymorphism (C → A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999; 8: 1443-1449.
40. Awad M, Pravica V, Perrey C et al. CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. Hum Immunol 1999; 60: 343-346.
41. Goris A, Epplen C, Fiten P et al. Analysis of an IFN-gamma gene (IFNG) polymorphism in multiple sclerosis in Europe: effect of population structure on association with disease. J Interferon Cytokine Res 1999; 19: 1037-1046.
42. Tanaka Y, Nakashima H, Hisano C et al. Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus. Immunogenetics 1999; 49: 266-271.
43. Nakashima H, Inoue H, Akahoshi M et al. The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus. FEBS Lett 1999; 453: 187-190.
44. Reich K, Westphal G, Schulz T et al. Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 prompter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 1999; 113: 214-220.
45. Cantagrel A, Navaux F, Loubet-Lescoulie P et al. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999; 42: 1093-1100.
46. Cookson S, Constantini PK, Clare M et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999; 30: 851-856.
47. Czaja AJ, Cookson S, Constantini PK, Clare M, Unnderhill JA, Donaldson PT. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis [see comments]. Gastroenterology 1999; 117: 645-652.
48. Helminen M, Lahdenpohja N, Hurme M. Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection. J Infect Dis 1999; 180: 496-499.
49. Tagore A, Gonsalkorale WM, Pravica V et al. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 1999; 54: 386-390.
50. Pickard C, Mann C, Sinnott P et al. Interleukin-10 (IL-10) promoter polymorphisms and multiple sclerosis. J Neuroimmunol 1999; 101: 207-210.
51. Crawley E, Isenberg D, Woo P, Kay R. Interleukin-10 promoter polymorphism and lupus nephritis: comment on the article by Mok et al [letter; comment]. Arthritis Rheum 1999; 42: 590-593.
52. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999; 30: 526-530.
53. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94: 3941-3946.
54. McKibbinn M, Clark B, Lee H, Isaacs JD, Gooi HC, Morrell AJ. No strong association between alleles of tumour necrosis factor alpha and interleukin-1 receptor antagonist and corneal melting associated with systemic vasculitis. Br J Ophthalmol 2000; 84: 395-398.
55. Papo M, Quer JC, Gutierrez C et al. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies [see comments]. Eur J Gastroenterol Hepatol 1999; 11: 413-420.
56. Sciacca FL, Ferri C, Vandenbroeck K et al. Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients. Neurology 1999; 52: 1896-1898.
57. Manzoli A, Andreotti F, Varlotta C et al. Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease [comment]. Cardiologia 1999; 44: 825-630.
58. Francis SE, Camp NJ, Dewberry RM et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999; 99: 861-866.
59. Fang XM, Schroder S, Hoeft A, Stuber F. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis [see comments]. Crit Care Med 1999; 27: 1330-1334.
60. Tjernstrom F, Hellmer G, Nived O, Truedsson L, Sturfelt G. Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17, DQ2) in determining susceptibility to systemic lupus erythematosus. Lupus 1999; 8: 103-108.
61. Wilkinson RJ, Patel P, Llewelyn M et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 1999; 189: 1863-1874.
62. Gonzalez Sarmiento R, Araoz P, Rodriguez R et al. Polymorphism of the IL1RN gene in Spanish patients with ulcerative colitis. Med Clin (Barc) 1999; 112: 778-779.
63. Jeremias J, Giraldo P, Durrant S, Ribeiro-Filho A, Witkin SS. Relationship between Ureaplasma urealyticum vaginal colonization and polymorphism in the interleukin-1 receptor antagonist gene. J Infect Dis 1999; 180: 912-914.
64. Jeremias J, Ledger WJ, Witkin SS. Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am J Obstet Gynecol 2000; 182: 283-285.
65. Schrijver HM, Crusius JB, Uitdehaag BM et al. Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology 1999; 52: 595-599.
66. Donn RP, Farhan AJ, Barrett JH, Thomson W, Worthington J, Ollier WE. Absence of association between interleukin 1 alpha and oligoarticular juvenile chronic arthritis in UK patients. Rheumatology (Oxford) 1999; 38: 171-175.
67. Galbraith GM, Hendley TM, Sanders JJ, Palesch Y, Pandey JP. Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis. J Clin Periodontol 1999; 26: 705-709.
68. Galbraith GM, Palesch Y, Gore EA, Pandey JP. Contribution of interleukin 1beta and KM loci to alopecia areata. Hum Hered 1999; 49: 85-89.
69. Huang D, Giscombe R, Zhou Y, Lefvert AK. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are asssociated with Wegener's granulomatosis [In Process Citation]. J Rheumatol 2000; 27: 397-401.
70. Nemetz A, Nosti-Escanilla MP, Molnar T et al. IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 1999; 49: 527-531.
71. Katila H, Hanninen K, Hurme M. Polymorphisms of the interleukin-1 gene complex in schizophrenia [see comments]. Mol Psychiatry 1999; 4: 179-181.
72. Dizier MH, Sandford A, Walley A, Philippi A, Cookson W, Demenais F. Indication of linkage of serum IgE levels to the interleukin-4 gene and exclusion of the contribution of the (-590 C to T) interleukin-4 promoter polymorphism to IgE variation. Genet Epidemiol 1999; 16: 84-94.
73. Parry RG, Gillespie KM, Parnham A, Clark AG, Mathieson PW. Interleukin-4 and interleukin-4 receptor polymorphisms in minimal change nephropathy. Clin Sci (Colch) 1999; 96: 665-668.
74. Noguchi E, Shibasaki M, Arinami T et al. No association between atopy/asthma and the ILe50Val polymorphism of IL-4 receptor. Am J Respir Crit Care Med 1999; 160: 342-345.
75. Noguchi E, Shibasaki M, Arinami T et al. Lack of association of a atopy/asthma and the interleukin-4 receptor alpha gene in Japanese. Clin Exp Allergy 1999; 29: 228-233.
76. Rosa-Rosa L, Zimmermann N, Bernstein JA, Rothenberg ME, Khurana Hershey GK. The R576 IL-4 receptor alpha allele correlates with asthma severity. J Allergy Clin Immunol 1999; 104: 1008-1014.
77. Tsukamoto K, Yoshida H, Watanabe S et al. Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenopausal Japanese women. J Hum Genet 1999; 44: 148-151.
78. Bagli M, Papassotiropoulos A, Knapp M et al. Association between an interleukin-6 promoter and 3́ flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci Lett 2000; 283: 109-112.
79. Huang D, Zheng C, Giscombe R, Matell G, Pirskanen R, Lefvert AK. Polymorphisms at -174 and in the 3́ flanking region of interleukin-6 (IL-6) gene in patients with myasthenia gravis. J Neuroimmunol 1999; 101: 197-200.
80. Fernandez-Real JM, Broch M, Vendrell J, Richart C, Ricart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 2000; 85: 1334-1339.
81. Abdallah AN, Cucchi-Mouillot P, Biteau N, Cassaigne A, Haras D, Iron A. Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection. Eur J Immunogenet 1999; 26: 249-255.
82. Trabetti E, Patuzzo C, Malerba G et al. Association of a lymphotoxin alpha gene polymorphism and atopy in Italian families. J Med Genet 1999; 36: 323-325.
83. Li Kam Wa TC, Mansur AH, Britton J et al. Association between -308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthma. Clin Exp Allergy 1999; 29: 1204-1208.
84. Barber MD, Powell JJ, Lynch SF, Gough NJ, Fearon KC, Ross JA. Two polymorphisms of the tumour necrosis factor gene do not influence survival in pancreatic cancer. Clin Exp Immunol 1999; 117: 425-429.
85. Bernal W, Moloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis [see comments]. J Hepatol 1999; 30: 237-241.
86. Somoskovi A, Zissel G, Seitzer U, Gerdes J, Schlaak M, Muller Quernheim J. Polymorphisms at position -308 in the promoter region of the TNF-alpha and in the first intron of the TNF-beta genes and spontaneous and lipopolysaccharide-induced TNF-alpha release in sarcoidosis. Cytokine 1999; 11: 882-687.
87. Majetschak M, Flohe S, Obertacke U et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999; 230: 207-214.
88. Pandey JP, Takeuchi F. TNF-alpha and TNF-beta gene polymorphisms in systemic sclerosis. Hum Immunol 1999; 60: 1128-1130.
89. Skeie GO, Pandey JP, Aarli JA, Gilhus NE. TNFA and TNFB polymorphisms in myasthenia gravis. Arch Neurol 1999; 56: 457-461.
90. Grainger DJ, Heathcote K, Chiano M et al. Genetic control of the circulating concentration of transforming growth factor type betal. Hum Mol Genet 1999; 8: 93-97.
91. Li B, Khanna A, Sharma V, Singh T, Suthanthiran M, August P. TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 1999; 33: 271-275.
92. McDonnell GV, Kirk CW, Middleton D et al. Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis. J Neurol 1999; 246: 1051-1058.
93. Hajeer AH, Lear JT, Ollier WE et al. Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomas. Br J Dermatol 2000; 142: 441-145.
94. Kunstmann E, Epplen C, Elitok E et al. Helicobacter pylori infection and polymorphisms in the tumor necrosis factor region. Electrophoresis 1999; 20: 1756-1761.
95. Allcock RJ, de la Concha EG, Fernandez-Arquero M et al. Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster [In Process Citation]. Hum Immunol 1999; 60: 1266-1273.
96. Mu H, Chen JJ, Jiang Y, King MC, Thomson G, Criswell LA. Tumor necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope. Arthritis Rheum 1999; 42: 438-442.
97. Mattey DL, Hassell AB, Dawes PT, Ollier WE, Hajeer A. Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis: influence on disease outcome. Arthritis Rheum 1999; 42: 2698-2704.
98. Bali D, Gourley S, Kostyu DD et al. Genetic analysis of multiplex rheumatoid arthritis families. Genes Immun 1999; 1: 28-36.
99. Al-Ansari AS, Ollier WE, Villarreal J, Ordi J, Teh LS, Hajeer AH. Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus. Tissue Antigens 2000; 55: 97-99.
100. Seki N, Yamaguchi K, Yamada A et al. Polymorphism of the 5′-flanking region of the tumor necrosis factor (TNF)-alpha gene and susceptibility to human T-cell lymphotropic virus type I (HTLV-I) uveitis. J Infect Dis 1999; 180: 880-883.
101. Kamizono S, Yamada A, Higuchi T, Kao H, Itoh K. Analysis of tumor necrosis factor-alpha production and polymorphisms of the tumor necrosis factor-alpha gene in individuals with a history of Kawasaki disease. Pediatr Int 1999; 41: 341-345.
102. Negoro K, Kinouchi Y, Hiwatashi N et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology 1999; 117: 1062-1068.
103. Date Y, Seki N, Kamizono S et al. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5′-flanking region of the TNFalpha gene and HLA genes. Arthritis Rheum 1999; 42: 2577-2582.
104. Hamaguchi K, Kimura A, Seki N et al. Analysis of tumor necrosis factor-alpha promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese. Tissue Antigens 2000; 55: 10-16.
105. Kaijzel EL, Brinkman BM, van Krugten MV et al. Polymorphism within the tumor necrosis factor alpha (TNF) promoter region in patients with ankylosing spondylitis. Hum Immunol 1999; 60: 140-144.
106. Hoffstedt J, Eriksson P, Hellstrom L, Rossner S, Ryden M, Arner P. Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia 2000; 43: 117-120.
107. Wihlborg C, Sjoberg J, Intaglietta M, Axdorph U, Pisa EK, Pisa P. Tumour necrosis factor-alpha cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia. Br J Haematol 1999; 104: 346-349.
108. Higham MA, Pride NB, Alikhan A, Morrell NW. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 281-284.
109. Rosen HR, Lentz JJ, Rose SL, Rabkin J, Corless CL, Taylor K, Chou S. Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation. Transplantation 1999; 68: 1898-1902.
110. Tiret L, Mallet C, Poirier O et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol 2000; 35: 29-35.
111. Stirnadel HA, Stockle M, Felger I, Smith T, Tanner M, Beck HP. Malaria infection and morbidity in infants in relation to genetic polymorphisms in Tanzania. Trop Med Int Health 1999, 4: 187-193.
112. Milner CR, Craig JE, Hussey ND, Norman RJ. No association between the -308 polymorphism in the rumour necrosis factor alpha (TNFalpha) promoter region and polycystic ovaries. Mol Hum Reprod 1999; 5: 5-9.
113. Mira JP, Cariou A, Grall F et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study [see comments]. JAMA 1999; 282: 561-568.
114. Rood MJ, van Krugten MV, Zanelli E et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000; 43: 129-134.
115. McGarry F, Walker R, Sturrock R, Field M. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA' B27. J Rheumatol 1999; 26: 1110-1116.
116. Jones DE, Watt FE, Grove J et al. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis [see comments]. J Hepatol 1999; 30: 232-236.
117. Chagani T, Pare PD, Zhu S et al. Prevalence of tumor necrosis factor-alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma. Am J Respir Crit Care Med 1999; 160: 278-282.
118. Takashige N, Naruse TK, Matsumori A et al. Genetic polymorphisms at the rumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens 1999; 54: 191-193.
119. Louis E, Peeters M, Franchimont D et al. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol 2000; 119: 64-68.
120. Hoffstedt J, Eriksson P, Hellstrom L, Rossner S, Ryden M, Arner P. Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia 2000; 43: 117-120.
121. Nuntayanuwat S, Dharakul T, Chaowagul W, Songsivilai S. Polymorphism in the promoter region of tumor necrosis factor-alpha gene is associated with severe meliodosis. Hum Immunol 1999; 60: 979-983.
122. Gordon MA, Oppenheim E, Camp NJ, di Giovine FSS, Duff GW, Gleeson D. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region [see comments]. J Hepatol 1999; 31: 242-247.
123. Tanaka A, Quaranta S, Mattalia A et al. The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis. J Hepatol 1999; 30: 826-829.
124. Swider C, Schnittger L, Bogunia-Kubik K et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 1999; 10: 143-146.
125. Roberts AK, Monzon-Bordonaba F, Van Deerlin PG et al. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol 1999; 180: 1297-1302.
126. Hirv K, Seyfarth M, Uibo R et al. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers. Scand J Gastroenterol 1999; 34: 1025-1032.
127. Fernandez-Arquero M, Arroyo R, Rubio A et al. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 1999; 53: 1361-1363.
128. Kato T, Honda M, Kuwata S et al. Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: no association with narcolepsy. Am J Med Genet 1999; 88: 301-304.
129. Hohjoh H, Nakayama T, Ohashi J et al. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 1999; 54: 138-145.
130. Hohjoh H, Nakayama T, Ohashi J et al. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 1999; 54: 138-145.
131. Seki N, Kamizono S, Yamada A et al. Polymorphisms in the 5′-flanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens 1999; 54: 194-197.